CGON – cg oncology, inc. - common stock (US:NASDAQ)

News

CG Oncology (CGON) had its price target raised by JPMorgan Chase & Co. from $65.00 to $91.00. They now have an "overweight" rating on the stock.
CG Oncology (CGON) was upgraded by Wall Street Zen from "sell" to "ho
CG Oncology (CGON) had its price target raised by HC Wainwright from $80.00 to $100.00. They now have a "buy" rating on the stock.
CG Oncology: Passing A Red Line For What I Would Call A Reasonable Valuation (Rating Downgrade) [Seeking Alpha]
CG Oncology (CGON) was downgraded by Wall Street Zen from "hold" to "
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com